These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 21211398

  • 1. [Clinical study of transcatheter arterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma by magnetic resonance imaging and functional diffusion-weighted imaging].
    Liu YB, Liang CH, Wang QS, Xie SF, Yu YX, Zhang ZL, Liu ZY.
    Zhonghua Yi Xue Za Zhi; 2010 Nov 09; 90(41):2922-6. PubMed ID: 21211398
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ, Zhang L, Ouyang YS.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2474-7. PubMed ID: 19080627
    [Abstract] [Full Text] [Related]

  • 3. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.
    J Magn Reson Imaging; 2008 Apr 16; 27(4):834-9. PubMed ID: 18383261
    [Abstract] [Full Text] [Related]

  • 4. [Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization].
    Xiao YP, Xiao EH, Luo JG, Bian DJ, Li MQ, He Z, Shang QL, Liang B.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec 16; 30(12):914-6. PubMed ID: 19173992
    [Abstract] [Full Text] [Related]

  • 5. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.
    Kim JH, Won HJ, Shin YM, Kim SH, Yoon HK, Sung KB, Kim PN.
    Ann Surg Oncol; 2011 Jun 16; 18(6):1624-9. PubMed ID: 21445671
    [Abstract] [Full Text] [Related]

  • 6. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.
    Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K.
    Cancer; 2010 Dec 01; 116(23):5452-60. PubMed ID: 20672352
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
    Sahin H, Harman M, Cinar C, Bozkaya H, Parildar M, Elmas N.
    J Vasc Interv Radiol; 2012 Feb 01; 23(2):241-7. PubMed ID: 22019180
    [Abstract] [Full Text] [Related]

  • 8. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ, Huang WS, Zhou B, Chen JW, Cai MY, Qian JS, Huang MS, Shan H, Zhu KS.
    Zhonghua Yi Xue Za Zhi; 2013 Sep 03; 93(33):2627-30. PubMed ID: 24360041
    [Abstract] [Full Text] [Related]

  • 9. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.
    Yuan Z, Ye XD, Dong S, Xu LC, Xu XY, Liu SY, Xiao XS.
    Eur J Radiol; 2010 Jul 03; 75(1):e9-14. PubMed ID: 19540083
    [Abstract] [Full Text] [Related]

  • 10. [Radiofrequency ablation combined with transcatheter arterial chemoembolization for the local recurrent tumor after resection of the adrenal metastasis from hepatocellular carcinoma--a case report].
    Yasumoto T, Hayashi S, Shimizu J, Dono K, Nakata S, Sato M, Kitada M, Shimano T.
    Gan To Kagaku Ryoho; 2009 Nov 03; 36(12):2371-3. PubMed ID: 20037426
    [Abstract] [Full Text] [Related]

  • 11. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM, Wang JH, Zhen ZJ, Chen HW, Cui WZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov 03; 26(11):1626-8. PubMed ID: 17121718
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D, Sponza M, Marzio A, Zanardi R, Bazzocchi M, Cemal Y.
    Radiol Med; 2002 Nov 03; 104(5-6):412-20. PubMed ID: 12589262
    [Abstract] [Full Text] [Related]

  • 13. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF.
    J Vasc Interv Radiol; 2006 Mar 03; 17(3):505-12. PubMed ID: 16567675
    [Abstract] [Full Text] [Related]

  • 14. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL, Furth EE, Olthoff K, Shaked A, Soulen MC.
    J Gastrointestin Liver Dis; 2009 Jun 03; 18(2):169-76. PubMed ID: 19565046
    [Abstract] [Full Text] [Related]

  • 15. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization.
    Dong S, Ye XD, Yuan Z, Xu LC, Xiao XS.
    Eur J Radiol; 2012 Mar 03; 81(3):472-7. PubMed ID: 21296517
    [Abstract] [Full Text] [Related]

  • 16. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Gao HJ, Liang HH, Chen MS, Peng ZW, Zhang YJ, Li P, Pang XH, Zhang YQ, Li JQ.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 23; 88(36):2529-32. PubMed ID: 19080642
    [Abstract] [Full Text] [Related]

  • 17. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
    Zhao M, Wu PH, Zeng YX, Xia JC, Zhang FJ, Xian LJ, Zhang YP, Zhou K, Fan WJ, Zhang L, Gao F, Zhou QM.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 11; 86(26):1823-8. PubMed ID: 17054858
    [Abstract] [Full Text] [Related]

  • 18. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFA Study Group.
    Cancer; 2010 Aug 01; 116(15):3638-44. PubMed ID: 20564097
    [Abstract] [Full Text] [Related]

  • 19. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.
    J Comput Assist Tomogr; 2010 Jul 01; 34(4):506-12. PubMed ID: 20657216
    [Abstract] [Full Text] [Related]

  • 20. Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection.
    Tashiro H, Aikata H, Waki K, Amano H, Oshita A, Kobayashi T, Tanimoto Y, Kuroda S, Tazawa H, Chayama K, Asahara T, Ohdan H.
    J Surg Oncol; 2011 Jul 01; 104(1):3-9. PubMed ID: 21656523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.